Correlation Between Elevation Oncology and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Elevation Oncology and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elevation Oncology and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elevation Oncology and Enliven Therapeutics, you can compare the effects of market volatilities on Elevation Oncology and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elevation Oncology with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elevation Oncology and Enliven Therapeutics.
Diversification Opportunities for Elevation Oncology and Enliven Therapeutics
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Elevation and Enliven is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Elevation Oncology and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Elevation Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elevation Oncology are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Elevation Oncology i.e., Elevation Oncology and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Elevation Oncology and Enliven Therapeutics
Given the investment horizon of 90 days Elevation Oncology is expected to generate 2.24 times more return on investment than Enliven Therapeutics. However, Elevation Oncology is 2.24 times more volatile than Enliven Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 100.00 in Elevation Oncology on September 12, 2024 and sell it today you would lose (25.50) from holding Elevation Oncology or give up 25.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Elevation Oncology vs. Enliven Therapeutics
Performance |
| Timeline |
| Elevation Oncology |
| Enliven Therapeutics |
Elevation Oncology and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elevation Oncology and Enliven Therapeutics
The main advantage of trading using opposite Elevation Oncology and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elevation Oncology position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |